HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Vaginal Cancer

Vaginal cancer is a rare form of cancer that begins in the cells of the vagina, the muscular tube connecting the uterus to the outer genitals. Though uncommon, it can affect women of any age. The most common type of vaginal cancer is squamous cell carcinoma, which originates in the thin, flat cells lining the vagina. The exact cause of vaginal cancer is often unclear, but certain factors may increase the risk, such as advanced age, exposure to the drug diethylstilbestrol (DES) before birth, human papillomavirus Symptoms of vaginal cancer may include abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, and unusual vaginal discharge. Diagnosing vaginal cancer typically involves a combination of a physical examination, Pap smear, biopsy, and imaging tests. Treatment options depend on the stage and type of cancer but may include surgery, radiation therapy, and chemotherapy. Early detection is crucial for successful treatment outcomes, emphasizing the importance of regular gynecological check-ups. As with many cancers, prevention plays a significant role. Getting vaccinated against HPV, practicing safe sex, and maintaining overall health through a balanced lifestyle can contribute to reducing the risk of vaginal cancer. If any concerning symptoms arise, it is essential to seek prompt medical attention for a thorough evaluation and appropriate management.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp